A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in United Therapeutics Corp stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 10,786 shares of UTHR stock, worth $4.17 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,786
Previous 1,588 579.22%
Holding current value
$4.17 Million
Previous $505,000 665.35%
% of portfolio
0.02%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$311.04 - $363.55 $2.86 Million - $3.34 Million
9,198 Added 579.22%
10,786 $3.87 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $29,902 - $41,794
131 Added 8.99%
1,588 $505,000
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $307,077 - $363,536
1,457 New
1,457 $331 Million
Q4 2023

Aug 14, 2024

BUY
$214.88 - $256.94 $23,636 - $28,263
110 Added 17.54%
737 $162 Million
Q3 2023

Aug 14, 2024

BUY
$211.82 - $248.24 $2,541 - $2,978
12 Added 1.95%
627 $142 Million
Q2 2023

Aug 14, 2024

BUY
$205.19 - $232.99 $6,976 - $7,921
34 Added 5.85%
615 $136 Million
Q1 2023

Aug 14, 2024

BUY
$212.99 - $276.17 $74,759 - $96,935
351 Added 152.61%
581 $130 Million
Q1 2022

Aug 14, 2024

SELL
$166.16 - $213.96 $225,645 - $290,557
-1,358 Reduced 85.52%
230 $41.3 Million
Q2 2021

Aug 30, 2024

SELL
$170.47 - $211.93 $231,498 - $287,800
-1,358 Reduced 85.52%
230 $41.3 Million
Q1 2021

Aug 30, 2024

SELL
$153.94 - $174.85 $70,812 - $80,431
-460 Reduced 66.67%
230 $38.5 Million
Q4 2020

Aug 30, 2024

BUY
$101.87 - $151.79 $46,860 - $69,823
460 Added 200.0%
690 $105 Million
Q1 2020

Aug 30, 2024

SELL
$79.39 - $115.35 $200,618 - $291,489
-2,527 Reduced 91.66%
230 $21.8 Million
Q4 2019

Aug 30, 2024

SELL
$78.31 - $95.34 $435,716 - $530,471
-5,564 Reduced 66.87%
2,757 $243 Million
Q3 2019

Aug 30, 2024

SELL
$74.85 - $85.99 $384,205 - $441,386
-5,133 Reduced 38.15%
8,321 $664 Million
Q2 2019

Aug 30, 2024

SELL
$76.06 - $120.81 $804,714 - $1.28 Million
-10,580 Reduced 44.02%
13,454 $1.05 Billion
Q1 2019

Aug 30, 2024

SELL
$107.15 - $126.84 $62,897 - $74,455
-587 Reduced 2.38%
24,034 $2.82 Billion
Q4 2018

Aug 30, 2024

BUY
$101.4 - $128.73 $2.34 Million - $2.97 Million
23,033 Added 1450.44%
24,621 $2.68 Billion
Q3 2018

Aug 30, 2024

BUY
$113.81 - $129.46 $157,740 - $179,431
1,386 Added 8.03%
18,654 $2.39 Billion
Q2 2018

Aug 30, 2024

BUY
$101.14 - $118.31 $188,626 - $220,648
1,865 Added 12.11%
17,268 $1.96 Billion
Q1 2018

Aug 30, 2024

BUY
$107.21 - $151.94 $707,264 - $1 Million
6,597 Added 74.91%
15,403 $1.73 Billion
Q4 2017

Aug 30, 2024

BUY
$118.58 - $151.28 $26,680 - $34,038
225 Added 2.62%
8,806 $1.3 Billion
Q3 2017

Aug 30, 2024

SELL
$114.6 - $136.81 $1.88 Million - $2.25 Million
-16,428 Reduced 65.69%
8,581 $1.01 Billion
Q2 2017

Aug 30, 2024

SELL
N/A
-942 Reduced 3.63%
25,009 $3.24 Billion
Q1 2017

Aug 30, 2024

BUY
N/A
24,363
25,951 $3.51 Billion

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.